Praxis Power2 study for Focal Epilepsy
About the study?
A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults with Focal Seizures.
Purpose of the study?
The main purpose of this research is to see how well vormatrigine works for treating focal onset seizures compared with placebo, as well as its safety and side effects compared with placebo.
Vormatrigine is a new investigational medicine that is taken once a day and is currently being studied to see if it can help people with focal onset seizures. This study drug could potentially offer better seizure control with fewer side effects.
Option to enroll in an extension study and receive vormatrigine treatment for up to 2 years, after completing participation in the initial study